S&P 500 7,722.60 +0.60%
Nasdaq 26,477.81 +1.18%
S&P/TSX 36,171.49 +0.63%
Apple 347.10 +0.93%
Nvidia 217.94 +0.90%
Microsoft 531.33 −0.24%
Shopify 232.93 −1.27%
Royal Bank 285.46 +0.42%
CAD/USD 0.7111 −0.36%
CLOSED · 21:50 ET
Market ClerkRecap
Tue Oct 27 · markets closed3 signals today116 insider buys this week · $63.9MCIRO short report next: Oct 31The week ahead
MJ
INSIDER · TVTX · Travere Therapeutics, Inc. · DIRECTOR

Meckler Jeffrey A

Every open-market transaction filed under this name, Sep 10 to Sep 10.

Filings
4
0 buys · 4 sells
Bought
—
open market, at cost
Sold
$1.3M
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 10TVTXTravere Therapeutics, Inc.DirectorSell3,100$68.09$211K−23.0%
Sep 10TVTXTravere Therapeutics, Inc.DirectorSell14,000$67.46$944K−22.3%
Sep 10TVTXTravere Therapeutics, Inc.DirectorSell1,200$66.15$79K−20.7%
Sep 10TVTXTravere Therapeutics, Inc.DirectorSell1,700$65.39$111K−19.8%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.